European Companies Search Engine
UK funding (£293,121): A novel approach to scaling up production of Brazzein - a natural, non-caloric protein sweetener and sugar alternative that can address UK and global sugar-related obesity … Ukri1 Sept 2023 UK Research and Innovation, United Kingdom
Overview
Text
A novel approach to scaling up production of Brazzein - a natural, non-caloric protein sweetener and sugar alternative that can address UK and global sugar-related obesity epidemics and health challenges
| Abstract | Tackling sugar-related obesity and health challenges through a novel approach to scaling up production of Brazzein - a natural, non-caloric sweetener and sugar alternative. |
| Category | Collaborative R&D |
| Reference | 10075378 |
| Status | Closed |
| Funded period start | 01/09/2023 |
| Funded period end | 28/02/2025 |
| Funded value | £293,121.00 |
| Source | https://gtr.ukri.org/projects?ref=10075378 |
Participating Organisations
| MAGELLAN LIFE SCIENCES LIMITED |
£182,549.00 |
| CENTRE FOR PROCESS INNOVATION LIMITED |
£110,572.00 |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Magellan Life Sciences Ltd., London.
The visualizations for "Magellan Life Sciences Ltd. - UK funding (£293,121): A novel approach to scaling up production of Brazzein - a natural, non-caloric protein sweetener and sugar alternative that can address UK and global sugar-related obesity …"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
